Sagittal craniosynostosis is the most common form of craniosynostosis, affecting approximately one in 5,000 newborns. We conducted, to our knowledge, the first genome-wide association study for nonsyndromic sagittal craniosynostosis (sNSC) using 130 non-Hispanic case-parent trios of European ancestry (NHW). We found robust associations in a 120-kb region downstream of BMP2 flanked by rs1884302 (P = 1.13 × 10 −14 , odds ratio (OR) = 4.58) and rs6140226 (P = 3.40 × 10 −11 , OR = 0.24) and within a 167-kb region of BBS9 between rs10262453 (P = 1.61 × 10 −10 , OR = 0.19) and rs17724206 (P = 1.50 × 10 −8 , OR = 0.22). We replicated the associations to both loci (rs1884302, P = 4.39 × 10 −31 and rs10262453, P = 3.50 × 10 −14 ) in an independent NHW population of 172 unrelated probands with sNSC and 548 controls. Both BMP2 and BBS9 are genes with roles in skeletal development that warrant functional studies to further understand the etiology of sNSC.
Skull development is a complex process that involves ongoing inter action between the bones of the skull and cranial soft tissues. The cranial vault is comprised of intramembranous bones joined by sutures of dense fibrous tissue that accommodate the growing brain. Bone is added at these sutures during growth, and the skull eventu ally ossifies completely. Craniosynostosis, the premature closure of one or more of the cranial vault sutures, is a common congenital anomaly. Approximately 80% of craniosynostosis occurs as an iso lated anomaly, called nonsyndromic craniosynostosis (NSC), with out major associated malformations 1 . Rare mutations in the FGFR2, TWIST1, FREM1, LRIT3, EFNA4 and RUNX2 duplications have been reported in a minor fraction of individuals with NSC [2] [3] [4] [5] [6] [7] [8] [9] . The remain der (~20%) of craniosynostosis cases are syndromic, occurring with one or more additional major malformations caused by singlegene mutations in one of at least eight genes (FGFR1, FGFR2, FGFR3, TWIST1, EFNB1, POR, MSX2 and RAB23), involving primarily the coronal sutures [10] [11] [12] .
The most common type of NSC is sNSC, which accounts for 40-58% of all cases 13, 14 . The etiology of sNSC is not well understood; however, the published literature suggests that it is a multifactorial condition in which both genetic and environmental factors have a role, as indicated by a higher rate of concordance in monozygotic as compared to dizygotic twins (30% compared to 0%, respectively) 15 , A genomewide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9 an increased maletofemale ratio (3:1) 1, 16 and a high risk of recurrence in affected families 17 . Several environmental factors have also been associated with sNSC, includ ing parity, prematurity, intrauterine con straint and maternal tobacco or nitrosatable drug use [18] [19] [20] [21] .
In an attempt to identify susceptibility loci for sNSC, we recruited 201 case parent trios and 13 nuclear families with at least one individual with sNSC (68% NHW and 32% mixedethnicity families). These participants were enrolled and evalu ated through the collaborative effort of the International Craniosynostosis Consortium (https://genetics.ucdmc.ucdavis.edu/icc. cfm). Samples were genotyped on the Illumina 1M Human Omni1Quad array. The final criteria for the current analyses were based on strict sNSC phenotype (no additional synostoses, congenital anomalies or developmental delay in the proband or any affected sibling) and NHW ethnicity as determined by selfreported ancestry and confirmed by principal component analy sis using EIGENSOFT 3.0 (ref. 22) . Application of these criteria reduced our discovery population to 130 caseparent trios.
After stringent qualitycontrol procedures, we retained genotypes for 915,307 SNPs (914,402 autosomal and 905 pseudoautosomal), which we analyzed using the transmission disequilibrium test (TDT) as implemented in PLINK v1.07 (ref. 23 ). This resulted in the iden tification of 21 SNPs, 18 on 20p12.3 and 3 on 7p14.3, that reached the genomewide significance threshold of P < 5 × 10 −8 ( Fig. 1 and  Supplementary Fig. 1 ). The 18 SNPs on chromosome 20 were in two linkage disequilibrium (LD) blocks (92 kb and 19 kb on chromosome 20p12.3; Fig. 2a , Table 1 and Supplementary Fig. 2) , with the most significant SNP, rs1884302 (P = 1.13 × 10 −14 ), located approximately 345 kb downstream of BMP2. Conditional analysis using extended TDT in UNPHASED 24 confirmed that rs1884302 led these signals (data not shown). Except for a predicted mRNA, BC038533, we did not identify any other known genes, copy number variants, tran scripts, microRNAs or regulatory elements in this region. However, we identified at least four highly conserved genome regions with multiple predicted sites for transcriptionfactor binding using bio informatic analysis in the vicinity of rs1884302 ( Supplementary  Fig. 3 ). Exonic resequencing of BMP2 in our cohort did not identify any variants with obvious deleterious effects. The three SNPs on chro mosome 7p14.3 span a region of 167 kb within BBS9 introns 4 and 15 ( Fig. 2b and Supplementary Fig. 4 ). RTPCR sequencing of comple mentary DNA (cDNA) from eight sNSC calvarial osteoblast cell lines revealed six BBS9 variants, but three were previously reported SNPs, and all were benign on the basis of bioinformatic protein prediction tools and conservation analysis (Online Methods). We also searched for twoway genegene interactions using the 100 most significant TDT genomewide association study (GWAS) SNPs using a condi tional logistic regression model 25 . No results were significant after correcting for multiple testing (1,247 tests, Bonferroni P ≤ 4 × 10 −5 ; Supplementary Table 1) .
Considering the male predominance of sNSC, we performed a sepa rate TDT analysis for 104 NHW trios with a male proband. The 21 SNPs on chromosomes 20 and 7 remained genomewide significant, with an additional pseudoautosomal marker reaching a low, but not genome wide statistically significant, P value (rs2522623, P = 5.75 × 10 −5 ) and thus did not meet our criteria for replication. This marker is located in PCDH11X (encoding protocadherin 11 Xlinked), which has not previously been reported to have a functional role in sNSC. Analysis of a larger cohort may show a stronger association to this locus.
From a total of 46 autosomal SNPs that showed significant and suggestive associations with P < 1 × 10 −5 , we prioritized 25 SNPs for the replication study (Supplementary Table 2 ). To confirm the observed signals, we genotyped a NHW replication popula tion of 172 unrelated cases with sNSC and 548 unaffected controls. We considered our data as a replication when the direction of effect of the alleles surpassing nominal significance was consistent between the discovery and replication datasets. All seven genotyped markers on chromosome 20 and four out of the five markers on 7p14.3 (with one SNP failing genotyping) were successfully replicated with metaanalysis P < 10 −9 (Supplementary Tables 2 and 3). There was little or no evidence of heterogeneity of the ORs in the two different sample sets for the 11 replicated SNPs. Additionally, genotypic TDT analysis indicated the effect of SNPs was consistent with an additive model (Supplementary Table 4) . We detected that, in most cases, the transmitted minor alleles conferred a 2.36 to 4.38fold risk of sNSC at the chromosome 20 markers, whereas the transmitted minor alleles at the chromosome 7 markers were associated with a decreased risk of sNSC (Supplementary Table 3 ). We were unable to replicate other signals from the GWAS TDT with P < 1 × 10 −5 . These associations could be false positives or were missed because of differences between the study design and statistical methods used for the discovery and replication stages. We also relied on selfreported maternal ethnicity instead of ancestryinformative markers for the replication cohort, which limited our ability to precisely assign ethnicity to the case control study. The effect of a geneenvironment interaction or the relatively small sample of the replication cohort may also have affected the findings.
We imputed borderline significant regions on chromosomes 3, l e t t e r s npg l e t t e r s genomewide significant SNPs. Fiftytwo intronic SNPs in DLG1 reached genomewide significance (Supplementary Table 5 ), but we previously could not replicate this association in our casecontrol sample (Supplementary Table 2 ). The lack of replication of a com mon variant may be a result of our small sample size, differences in study design between our GWAS and replication datasets or rare variants that contribute to risk. We performed the imputation using the 1000 Genomes data as the reference panel, which includes some sequence variants with minor allele frequencies (MAFs) <1%. Given that sNSC has a prevalence of 1 in 5,000, we suspect that rare func tional variants not identified by 1000 Genomes may be involved, and sequencing of the associated region will be necessary. We found no statistically significant signals after the imputation at the other loci. Using these modestly sized populations, we discovered and repli cated common genetic variants in at least two loci that contribute to sNSC. The locus on chromosome 20 is located in the vicinity of BMP2, which has a role in skeletal development. BMP2 is a member of the TGFβ superfamily that activates SMAD1, SMAD5 and SMAD8 and, together with other osteogenic transcription factors such as RUNX2, ultimately regulates osteoblast development 27 .
An interesting observation in humans and animal models is that mutations with opposite effects in the same gene result in cranio synostosis (accelerated ossification) or parietal foramina or large fontanelles (deficient ossification) phenotypes. This holds true for mutations in at least four genes: MSX2 (refs. [28] [29] [30] , TWIST1 (refs. 31,32), RUNX2 (refs. 6,7,33) and Nell1 (refs. 34,35) . Consistent with this, gainoffunction mutations in ALX4, a gene that is associ ated with parietal foramina, have previously been identified in sNSC probands by our group 36 . Similarly, a variant in BMP2, p.Ser37Ala, has been associated with osteoporosis 37 ; thus, if p.Ser37Ala results in loss of function, one can speculate that gainoffunction variants causing overexpression of BMP2 would result in a phenotype of accel erated ossification and, potentially, craniosynostosis. Additionally, a limbspecific regulatory element located 110 kb downstream of BMP2 is mutated in brachydactyly type A2 (ref. 38) . Therefore, we predict that a skullspecific BMP2 regulatory element is located within or near the association region. Also, noncoding SNPs can affect variation in the expression of one or many genes. Even though none of our top hits was in the expression quantitative trait loci databases, this may be because no human expression quantitative trait loci studies have been conducted in the skull suture tissues.
The GWAS and the replication analyses also showed evidence for association on chromosome 7p14 within an intronic region of BBS9. BBS9 is a component of the multiprotein complex BBSome, which has crucial roles in intraflagellar transport and moving cargo molecules in and out of cilia. Lossoffunction mutations in BBS9 have been found in patients with BardetBiedl syndrome (BBS) 39 . BBS arises from defects of primary cilia that function as a platform npg l e t t e r s for many important signaling events involving, at least, PDGFRα, hedgehog, epidermal growth factor and the 5HT 6 serotonin receptor [40] [41] [42] [43] [44] . Although BBS does not present with suture pheno types, it does present with a skeletal phenotype (polydactyly) and orofacial anomalies 39 . It is noteworthy that aberrant signaling of PDGFRα and epidermal growth factor or hedgehog has been implicated in craniofacial development [45] [46] [47] [48] [49] . In addition, it has been shown that FGF signaling regulates cilia length and function during the development of zebrafish and Xenopus 50 . Thus, it is possible that craniosynostosiscausing gainoffunction mutations in FGFR genes also work through aberrant assembly and/or signaling of cilia. It remains to be seen whether gainoffunction mutations or overex pression of BBS9 would influence suture fusion. Three of the genes in the vicinity of the association on chromosome 7 (RP9P, KBTBD2 and FKBP9) are pseudogenes, and the remaining two genes in the region, RP9 and NT5C3, have no known role in skeletal development and cause retinitis pigmentosa and hemolytic anemia, respectively 51, 52 . This region is located approximately 14 Mb telomeric of TWIST1 and is thus unlikely to affect its function. Our findings implicate variants within or near genes with relevant function in skeletal development, suggesting a major genetic effect for sNSC. A larger sample size will be needed to detect additional sus ceptibility genes with moderate genetic effects. The lack of Mendelian segregation suggests a more complex pattern of inheritance for sNSC. The causative variants may be of low frequency and in LD with the common alleles associated with sNSC in this study. Another possibility is that one or more environmental factors interacting with genetic variants contribute to sNSC. Less likely, but still possible, are oligogenic inheritance, genegene interactions, imprinting, epigenetic changes or incomplete penetrance of the variants.
We identified two biologically plausible candidate genes in our study, BMP2 and BBS9, both of which are involved in skeletal development. Functional studies of these genes, such as RNA sequencing and, pos sibly, tiling arrays of the regions to look for noncoding or microRNAs, are warranted. The potential contribution of these loci to other types of NSC is worthy of investigation. Our results represent the first major step toward deciphering the genetic etiology of sNSC.
MEtHOdS
Methods and any associated references are available in the online version of the paper. We searched for twoway genegene interactions using the 100 most significant SNPs from the 130 NHW trio TDT analysis. We performed a genotypic TDT for the interaction of each pair of SNPs, excluding results from SNP pairs on the same chromosome because of longrange LD (1,247 tests). For each caseparents trio, we generated 15 pseudo controls matched to each proband as a function of the parental genotypes of the two considered SNPs. Pseudo controls for each case were comprised of one of the possible twolocus genotypes that was not transmitted to the case. Using these 15 pseudo controls and matched cases, we fitted a conditional logistic regression model 25 to test for epistatic interactions that incorporate additive and domi nance effects at the two loci. The 'trio' R package v1.4.24 was used to perform these tests 56 .
Conditional analysis was performed to identify additional SNPs potentially masked by the primary significant SNP using the conditional extended TDT for trio data 57 as implemented in UNPHASED v3.0.9 (ref. 24) . A metaanalysis was performed by combining the traitmarker associations of the discovery TDT and replication casecontrol study using a fixedeffects model after test ing for interstudy heterogeneity 58 .
